Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?

Millard SM, Fisk NM.

Bioessays. 2013 Mar;35(3):173-82. doi: 10.1002/bies.201200087. Epub 2012 Nov 26. Review.

PMID:
23184477
2.
3.

Exosomes derived from mesenchymal stem cells.

Yu B, Zhang X, Li X.

Int J Mol Sci. 2014 Mar 7;15(3):4142-57. doi: 10.3390/ijms15034142. Review.

4.

Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.

Lai RC, Chen TS, Lim SK.

Regen Med. 2011 Jul;6(4):481-92. doi: 10.2217/rme.11.35. Review.

5.

Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.

Liang X, Ding Y, Zhang Y, Tse HF, Lian Q.

Cell Transplant. 2014;23(9):1045-59. doi: 10.3727/096368913X667709. Review.

PMID:
23676629
6.

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

Williams AR, Hare JM.

Circ Res. 2011 Sep 30;109(8):923-40. doi: 10.1161/CIRCRESAHA.111.243147. Review.

7.

Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?

Bernardo ME, Pagliara D, Locatelli F.

Bone Marrow Transplant. 2012 Feb;47(2):164-71. doi: 10.1038/bmt.2011.81. Epub 2011 Apr 11. Review.

PMID:
21478914
8.

Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia.

Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G, Emery D, Bodiga S, Eaton F, Péault B, Mosca F, Lazzari L, Thébaud B.

Thorax. 2013 May;68(5):475-84. doi: 10.1136/thoraxjnl-2012-202323. Epub 2012 Dec 4.

PMID:
23212278
9.

Lessons from genetically altered mesenchymal stem cells (MSCs): candidates for improved MSC-directed myocardial repair.

Alfaro MP, Young PP.

Cell Transplant. 2012;21(6):1065-74. doi: 10.3727/096368911X612477. Epub 2011 Nov 11. Review.

PMID:
22080676
10.

Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung.

Hoffman AM, Paxson JA, Mazan MR, Davis AM, Tyagi S, Murthy S, Ingenito EP.

Stem Cells Dev. 2011 Oct;20(10):1779-92. doi: 10.1089/scd.2011.0105. Epub 2011 Jul 6.

11.

Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.

Wang J, Liao L, Tan J.

Expert Opin Biol Ther. 2011 Jul;11(7):893-909. doi: 10.1517/14712598.2011.574119. Epub 2011 Mar 30. Review.

PMID:
21449634
12.

Emerging therapeutic approaches for multipotent mesenchymal stromal cells.

Caimi PF, Reese J, Lee Z, Lazarus HM.

Curr Opin Hematol. 2010 Nov;17(6):505-13. doi: 10.1097/MOH.0b013e32833e5b18. Review.

13.

The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.

Kim EJ, Kim N, Cho SG.

Exp Mol Med. 2013 Jan 10;45:e2. doi: 10.1038/emm.2013.2. Review.

14.

Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.

Li F, Whyte N, Niyibizi C.

Biochem Biophys Res Commun. 2012 Oct 5;426(4):475-9. doi: 10.1016/j.bbrc.2012.08.095. Epub 2012 Aug 29.

PMID:
22960177
15.

A mesenchymal stem cell potency assay.

Jiao J, Milwid JM, Yarmush ML, Parekkadan B.

Methods Mol Biol. 2011;677:221-31. doi: 10.1007/978-1-60761-869-0_16.

16.

Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.

Zhang Y, Liao S, Yang M, Liang X, Poon MW, Wong CY, Wang J, Zhou Z, Cheong SK, Lee CN, Tse HF, Lian Q.

Cell Transplant. 2012;21(10):2225-39. doi: 10.3727/096368912X653020. Epub 2012 Jul 5.

PMID:
22776744
17.

Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis.

Eseonu OI, De Bari C.

Rheumatology (Oxford). 2015 Feb;54(2):210-8. doi: 10.1093/rheumatology/keu377. Epub 2014 Oct 6. Review.

PMID:
25288785
18.

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.

Yi T, Song SU.

Arch Pharm Res. 2012 Feb;35(2):213-21. doi: 10.1007/s12272-012-0202-z. Epub 2012 Feb 28. Review.

PMID:
22370776
19.

Concise review: role of mesenchymal stem cells in wound repair.

Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA.

Stem Cells Transl Med. 2012 Feb;1(2):142-9. doi: 10.5966/sctm.2011-0018. Review.

20.

Mesenchymal stem cell-based therapy.

Mundra V, Gerling IC, Mahato RI.

Mol Pharm. 2013 Jan 7;10(1):77-89. doi: 10.1021/mp3005148. Epub 2012 Dec 24. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk